Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing

References

• AgustiANVillaverdeJMTogoresB1999Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary diseaseEur Respir J,14523810543270
   PubMed Web of Science ®Google Scholar
• AnsarinKChatkinJMFerreiraIM2001Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary functionEur Respir J17934811488329
   PubMed Web of Science ®Google Scholar
• [ATS] American Thoracic Society1999Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and childrenAm J Resp Crit Care Med16021041710588636
   PubMed Web of Science ®Google Scholar
• [ATS] ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories2002ATS statement: Guidelines for the six-minute-walk testAmer J Resp Crit Care Med1661111712091180
   PubMed Web of Science ®Google Scholar
• BaramkiDKoesterJAndersonAJ2002Modulation of t-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomerJ Allergy Clin Immunol1094495411897990
   PubMed Web of Science ®Google Scholar
• ChoSHHarrtleroadJYOhCK2001(S)-albuterol increases the production of histamine and IL-4 in mast cellsInt Arch Allergy Immunol1244788411340331
   PubMed Web of Science ®Google Scholar
• CorradiMMajoriMCaccianiGC1999Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary diseaseThorax54572510377199
   PubMed Web of Science ®Google Scholar
• CostelloJ1999Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterolJ Allergy Clin Immunol104S61810452790
   PubMed Web of Science ®Google Scholar
• DattaDVitaleALahirsB2003An evaluation of nebulized levalbuterol in stable COPDChest124844912970007
   PubMed Web of Science ®Google Scholar
• DelenFMSippelJMOsborneML2003Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPDChest11769570110712993
   PubMed Web of Science ®Google Scholar
• EakinEGResnikoffPMPrewittLM1998Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire University of California, San DiegoChest113619249515834
   PubMed Web of Science ®Google Scholar
• FrieriMPergolizzitRMillanC2000Cytokine, chemokine and nitric oxide (NO) release in stimulated small airway epithelial cells (SAEC) treated with β2-agonist enantiomers of albuterol [abstract]J Allergy Clin Immunol105S2923
   Web of Science ®Google Scholar
• GauvreauGMJordanaMWatsonRM1997Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjectsAm J Respir Crit Care Med1561738459412549
   PubMed Web of Science ®Google Scholar
• [GOLD] Global Initiative for Chronic Obstructive Lung Disease2005Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Updated 2005 (Based on an April 1998 NHLBI/WHO Workshop) [online]Accessed on 23 August 2005 URL: http://www.goldcopd.com/download.asp?intId=231
   Google Scholar
• HandleyD1999The asthma-like pharmacology and toxicology of (S)-isomers of β agonistsJ Allergy Clin Immunol104S697610452791
   PubMed Web of Science ®Google Scholar
• HandleyD2001Single-isomer β-agonistsPharmacotherapy21S217
   Web of Science ®Google Scholar
• HendelesL2003Levalbuterol is not more cost-effective than albuterol for COPD [letter]Chest1241176812970057
   PubMed Web of Science ®Google Scholar
• KharitonovSABarnesPJ2004Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary diseaseProc Am Thorac Soc1191916113434
   PubMedGoogle Scholar
• KupferbergDHKaplanRMSlymenDJ2005Minimal clinically important difference for the USCD shortness of breath questionnaireJ Cardiopulm Rehabil26370716327533
   PubMedGoogle Scholar
• ManolitsasNDWangJDevaliaJL1995Am J Respir Crit Care Med1511925307767541
   PubMed Web of Science ®Google Scholar
• MaziakWLoukidesSCulpittS1998Exhaled nitric oxide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med15799810029517624
   PubMed Web of Science ®Google Scholar
• MazzoniLNaefRChapmanID1994Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of β2-selective sympathomimeticsPulm Pharmacol7367767549224
   PubMedGoogle Scholar
• MorleyJMazzoniLChapmanID1995Rac-albuterol causes polymorphonuclear leukocyte accumulation in the pulmonary airways of the guinea-pig [abstract]Am J Respir Crit Care Med151A604
   Google Scholar
• PageCPMorleyJ1999Contrasting properties of albuterol stereoisomersJ Allergy Clin Immunol104S314110452786
   PubMed Web of Science ®Google Scholar
• RedelmeierDABayoumiAMGoldsteinRS1997Interpreting small differences in functional status: the six minute walk test in chronic lung disease patientsAm J Respir Crit Care Med1551278829105067
   PubMed Web of Science ®Google Scholar
• TempletonABChapmanIDChilversER1998Effects of s-albuterol on human isolated bronchusPulm Pharmacol Ther1169802957
   PubMed Web of Science ®Google Scholar
• TruittTWitkoJHalpernM2003Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthmaChest1231283512527613
   PubMed Web of Science ®Google Scholar
• VolcheckGWGleichGJKitaH1998Pro- and anti-inflammatory effects of beta adrenergic agonists on eosinophil response to IL-5 [abstract]J Allergy Clin Immunol101S35
   Web of Science ®Google Scholar
• WangZBramleyAMMcNamaraA1994Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigsAm J Respir Crit Care Med14996058143062
   PubMed Web of Science ®Google Scholar
• ZietkowskiZKucharewiczIBodzenta-LukaszykA2005The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary diseaseRespir Med998162415939243
   PubMed Web of Science ®Google Scholar